Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-12-15

Clinical Trial Update: Sodium Oxybate in Patients With Chronic Fatigue Syndrome. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating sodium oxybate in Chronic Fatigue Syndrome was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Oxybate (Sodium Oxybate)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Chronic Fatigue Syndrome | Phase 4 | Status: WITHDRAWN